Namrata (Neena) Vijayvergia, MD

Department of Hematology/Oncology

This physician is not currently rated. Why?

Request an Appointment

Call 888-369-2427

Request Online

Clinical Locations

Primary Location
Fox Chase Cancer Center

Assistant Chief, Gastrointestinal Medical Oncology

Associate Professor, Department of Hematology/Oncology

Medical Director, Medical Oncology

Specialties

Research Program

Nuclear Dynamics and Cancer

Key Awards

Medical Oncology

Treatment Philosophy

Coming from a family of 12 doctors, I wanted to be one for as long as I can remember. After graduating from medical school in India, I pursued Internal Medicine training at Temple University Hospital in Philadelphia, where I also served as a chief medical resident. During that time I became interested in oncology and clinical research. I recently completed my fellowship in hematology/oncology at Temple/Fox Chase Cancer Center and have been fortunate enough to stay on as faculty. Early in my training, I realized that I wanted to dedicate my career to help discover new therapies for patients with gastrointestinal cancers, with a particular focus on pancreatic and neuroendocrine malignancies. We have made significant progress but a lot still needs to be done... Expand

Educational Background

Fellow, Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, 2012-2015
Resident, Temple University Hospital, Philadelphia, PA, 2008-2011
Bachelor of Medicine and Bachelor of Surgery (MBBS), Jawaharlal Nehru Medical College, University of Rajasthan, Ajmer, India, 2007

Certifications

American Board of Internal Medicine

Memberships

American Society of Clinical Oncology
American Society of Hematology
North American Neuroendocrine Tumor Society
American Medical Association
Indian Medical Association

Honors & Awards

Philadelphia Magazine Top Doctors, 2024
Top Physicians Under 40 2020, Pennsylvania Medical Society

Melvin Ward

Neuroendocrine Tumors

My care team at Fox Chase had such a confident and laid-back demeanor. We were on the same page, and their expertise made me feel more secure.

VIEW PATIENT STORY

Ardelle Clarke

Neuroendocrine Tumors

I plan on having a very, very long life. I’m 66 years old and I run a daycare in Havertown, Pennsylvania. Until I was diagnosed, I had no symptoms to speak of and had lived a healthy lifestyle. That’s why when doctors told me I had carcinoid tumors, I had trouble believing I was really sick.

VIEW PATIENT STORY

Research Interests

Neuroendocrine Tumors

Pancreatic Cancer

Outcomes Research

Selected Publications

Vijayvergia, N., Denlinger, C., Survivorship in Non-Small Cell Lung Cancer:Challenges Faced and Steps Forward. Manuscript submitted to JNCCN. 2015 PubMed

Vijayvergia, N., Dotan, E., Cohen, S.J., Predictors of long-term survival with metastatic pancreatic cancer (mPC) in the gemcitabine era: The Fox Chase Cancer Center experience. Manuscript submitted to Cancer. 2015 PubMed

Matthews, E., Zhou, L., Vijayvergia, N., El-Deiry, W., A Multiplexed Marker-based Algorithm for Diagnosis of Carcinoma of Unknown Primary Using Circulating Tumor Cells, Poster accepted for presentation at AACR 2015. 2014

Vijayvergia, N., Cohen, S.J., Predictors of long-term survival with metastatic pancreatic cancer (mPC) in the gemcitabine era: The Fox Chase Cancer Center experience. J Clin Oncol 33, 2015 (suppl 3; abstr 253). 2014

Vijayvergia, N., Engstrom, P.F., Molecular profiling of advanced stage Neuro Endocrine Tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. Poster presented at NANETS annual symposium 2014 and GI ASCO Symposium 2015 (JClin Oncol 33, 2015 (suppl 3; abstr 245)

Vijayvergia N, Mehra R. Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2014 Sep;74(3):437-46

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.